Clear Search sequence regions

The US National Cancer Institute (NCI) 60 human tumour cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumours in anticancer drug screening. This screening model was rapidly recognized as a rich source of information about the mechanisms of growth inhibition and tumour-cell kill. Recently, its role has changed to that of a service screen supporting the cancer research community. Here I review the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy.


Robert H Shoemaker. The NCI60 human tumour cell line anticancer drug screen. Nature reviews. Cancer. 2006 Oct;6(10):813-23

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 16990858

View Full Text